The language of chromatin modification in human cancers
The genetic information of human cells is stored in the context of chromatin, which is
subjected to DNA methylation and various histone modifications. Such a 'language'of …
subjected to DNA methylation and various histone modifications. Such a 'language'of …
Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
Z Zeng, M Fu, Y Hu, Y Wei, X Wei, M Luo - Molecular Cancer, 2023 - Springer
Cancer stem cells (CSCs), initially identified in leukemia in 1994, constitute a distinct subset
of tumor cells characterized by surface markers such as CD133, CD44, and ALDH. Their …
of tumor cells characterized by surface markers such as CD133, CD44, and ALDH. Their …
Biology and relevance of human acute myeloid leukemia stem cells
D Thomas, R Majeti - Blood, The Journal of the American …, 2017 - ashpublications.org
Evidence of human acute myeloid leukemia stem cells (AML LSCs) was first reported nearly
2 decades ago through the identification of rare subpopulations of engrafting cells in …
2 decades ago through the identification of rare subpopulations of engrafting cells in …
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML
For two decades, leukaemia stem cells (LSCs) in chronic myeloid leukaemia (CML) and
acute myeloid leukaemia (AML) have been advanced paradigms for the cancer stem cell …
acute myeloid leukaemia (AML) have been advanced paradigms for the cancer stem cell …
2-Oxoglutarate-dependent dioxygenases in cancer
JA Losman, P Koivunen, WG Kaelin Jr - Nature Reviews Cancer, 2020 - nature.com
Oxoglutarate-dependent dioxygenases (2OGDDs) are a superfamily of enzymes that play
diverse roles in many biological processes, including regulation of hypoxia-inducible factor …
diverse roles in many biological processes, including regulation of hypoxia-inducible factor …
Leukemogenic chromatin alterations promote AML leukemia stem cells via a KDM4C-ALKBH5-AXL signaling axis
J Wang, Y Li, P Wang, G Han, T Zhang, J Chang, R Yin… - Cell stem cell, 2020 - cell.com
Summary N 6-methyladenosine (m 6 A) is a commonly present modification of mammalian
mRNAs and plays key roles in various cellular processes. m 6 A modifiers catalyze this …
mRNAs and plays key roles in various cellular processes. m 6 A modifiers catalyze this …
[HTML][HTML] Epigenetics and cancer stem cells: unleashing, hijacking, and restricting cellular plasticity
EN Wainwright, P Scaffidi - Trends in cancer, 2017 - cell.com
Epigenetic mechanisms have emerged as key players in cancer development which affect
cellular states at multiple stages of the disease. During carcinogenesis, alterations in …
cellular states at multiple stages of the disease. During carcinogenesis, alterations in …
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism
Recent studies on mutations in cancer genomes have distinguished driver mutations from
passenger mutations, which occur as byproducts of cancer development. The cancer …
passenger mutations, which occur as byproducts of cancer development. The cancer …
[HTML][HTML] In colorectal cancer cells with mutant KRAS, SLC25A22-mediated glutaminolysis reduces DNA demethylation to increase WNT signaling, stemness, and drug …
Background & Aims Mutant KRAS promotes glutaminolysis, a process that uses steps from
the tricarboxylic cycle to convert glutamine to α-ketoglutarate and other molecules via …
the tricarboxylic cycle to convert glutamine to α-ketoglutarate and other molecules via …
Escape from treatment; the different faces of leukemic stem cells and therapy resistance in acute myeloid leukemia
Standard induction chemotherapy, consisting of an anthracycline and cytarabine, has been
the first-line therapy for many years to treat acute myeloid leukemia (AML). Although this …
the first-line therapy for many years to treat acute myeloid leukemia (AML). Although this …